España
India
Italia
대한민êµ
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
scPharmaceuticals
SCPH
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$3.46
0.1
2.98%
At close: -
$3.46
0
0.00%
After Hours: 4:02 PM EDT
Get Report
Comment
scPharmaceuticals (SCPH) Forecast
News
Earnings
scPharmaceuticals (SCPH) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for scPharmaceuticals (NASDAQ:SCPH) Stock
scPharmaceuticals Stock (NASDAQ: SCPH)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, November 14, 2024
HC Wainwright & Co. Reiterates Buy on scPharm...
Benzinga Newsdesk
ScPharmaceuticals shares are trading lower af...
Benzinga Newsdesk
Craig-Hallum Maintains Buy on scPharmaceutica...
Benzinga Newsdesk
Wednesday, November 13, 2024
scPharmaceuticals Q3 Sales $10.03M Miss $10.8...
Benzinga Newsdesk
Earnings Scheduled For November 13, 2024
Benzinga Insights
Tuesday, November 12, 2024
scPharmaceuticals's Earnings Outlook
Benzinga Insights
Monday, August 19, 2024
HC Wainwright & Co. Reiterates Buy on scPharm...
Benzinga Newsdesk
Wednesday, August 14, 2024
scPharmaceuticals Q2 EPS $(0.36) Up From $(0....
Benzinga Newsdesk
Monday, August 12, 2024
scPharmaceuticals Prices $50M Public Offering...
Benzinga Newsdesk
Heart Failure-Focused scPharmaceuticals Secures FDA Approval For Expanded Use Of Furoscix, Receives Funding To Expand Commercialization
Vandana Singh
scPharmaceuticals Announces Proposed Underwri...
Benzinga Newsdesk
scPharmaceuticals Announced Non-dilutive Fina...
Benzinga Newsdesk
The FDA Approves scPharmaceuticals' Supplemen...
Benzinga Newsdesk
scPharmaceuticals Announced Topline Results F...
Benzinga Newsdesk
Thursday, July 25, 2024
scPharmaceuticals Announces Filing Acceptance...
Benzinga Newsdesk
Wednesday, May 15, 2024
HC Wainwright & Co. Reiterates Buy on scPharm...
Benzinga Newsdesk
Tuesday, May 14, 2024
scPharmaceuticals Q1 2024 GAAP EPS $(0.36) Be...
Benzinga Newsdesk
Wednesday, April 24, 2024
scPharmaceuticals Enrolls First Participant I...
Benzinga Newsdesk
Friday, April 05, 2024
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Thursday, March 14, 2024
HC Wainwright & Co. Reiterates Buy on scPharm...
Benzinga Newsdesk
Wednesday, March 13, 2024
Recap: scPharmaceuticals Q4 Earnings
Benzinga Insights
scPharmaceuticals Q4 2023 GAAP EPS $(0.35) Be...
Benzinga Newsdesk
Earnings Scheduled For March 13, 2024
Benzinga Insights
Tuesday, March 12, 2024
A Preview Of scPharmaceuticals's Earnings
Benzinga Insights
Monday, January 22, 2024
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
Thursday, January 04, 2024
ScPharmaceuticals Sees Prelim. FY23 FUROSCIX ...
Benzinga Newsdesk
ScPharmaceuticals Sees Prelim. Q4 FUROSCIX Re...
Benzinga Newsdesk
Wednesday, November 08, 2023
Recap: scPharmaceuticals Q3 Earnings
Benzinga Insights
scPharmaceuticals Q3 EPS $(0.41) Misses $(0.3...
Benzinga Newsdesk
Earnings Scheduled For November 8, 2023
Benzinga Insights
Tuesday, November 07, 2023
Earnings Preview: scPharmaceuticals
Benzinga Insights
Tuesday, September 19, 2023
scPharmaceuticals Announces Feedback From Two...
Benzinga Newsdesk
Thursday, September 07, 2023
Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2023
Benzinga Insights
Craig-Hallum Initiates Coverage On scPharmace...
Benzinga Newsdesk
Friday, August 11, 2023
HC Wainwright & Co. Reiterates Buy on scPharm...
Benzinga Newsdesk
Thursday, August 10, 2023
scPharmaceuticals Q2 EPS $(0.36) Beats $(0.37...
Benzinga Newsdesk
Earnings Scheduled For August 10, 2023
Benzinga Insights
Wednesday, August 09, 2023
Earnings Outlook For scPharmaceuticals
Benzinga Insights
Wednesday, August 02, 2023
HC Wainwright & Co. Reiterates Buy on scPharm...
Benzinga Newsdesk
Tuesday, August 01, 2023
scPharmaceuticals Announces Type C Meeting Feedback From FDA On Potential Heart Failure Class IV Indication Expansion
Happy Mohamed
Wednesday, July 19, 2023
The Latest Analyst Ratings for scPharmaceuticals
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on scPharm...
Benzinga Newsdesk
Thursday, June 29, 2023
Short Interest Sector Focus: Healthcare Sector
Christopher Sappo
Wednesday, June 28, 2023
Short Interest Sector Focus: Healthcare Sector
Christopher Sappo
Friday, June 23, 2023
scPharmaceuticals Inc. Announces Addition to ...
Benzinga Newsdesk
Thursday, June 08, 2023
Analyst Ratings for scPharmaceuticals
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on scPharm...
Benzinga Newsdesk
Thursday, May 11, 2023
Maxim Group Maintains Buy on scPharmaceutical...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on scPharm...
Benzinga Newsdesk
Wednesday, May 10, 2023
scPharmaceuticals Q1 EPS $(0.30) Beats $(0.36) Estimate
Happy Mohamed
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch